BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 15, 2003
View Archived Issues
Phytopharm reports quarterly development highlights
Read More
First-quarter progress at Medivir
Read More
Ciclosporin analogues for autoimmune diseases designed at Enanta
Read More
Memory Pharmaceuticals presents new PDE4 inhibitors for use in cognition disorders
Read More
Novel glucose-lowering 11CBy antagonists identified at GSK
Read More
Antitumor dolastatin derivative isolated and tested by Spanish researchers
Read More
Allergan patent covers new analgesic agents, their preparation and use
Read More
Bayer researchers present new adenosine uptake inhibitors
Read More
Scientists at Janssen identify new delta opioid receptor agonists
Read More
Checkpoint kinase inhibitors and their use as adjuvants in DNA-damaging cancer therapy
Read More
New antiobesity MCHR1 antagonists in GSK pipeline
Read More
Dietary omega n-3 LCPUFAs reduce the risk for AMD
Read More
Timolol-LA reported as effective as timolol maleate in reducing ocular hypertension
Read More
Regulatory approval sought for Fendrix
Read More
Theralux granted orphan drug status for CML
Read More
QLT discontinues phase III trials of tariquidar in NSCLC
Read More
Rifaximin does not promote antibacterial resistance in Salix study
Read More
At-home phase IIb study begins for ED treatment PT-141
Read More
Onconase to be tested in federal SARS program
Read More
Trillium Therapeutics approved as new name for Transplantation Technologies
Read More
IND filed for phase II trials of SPI-0211 in postoperative ileus
Read More
Phase IIa trial evaluates VR-004 delivered via lungs for ED
Read More
Dacogen granted fast track status for MDS
Read More
FDA advisory committee hands down favorable decision on atazanavir
Read More
Completely new approach to cancer treatment given the go-ahead by the FDA for multiple myeloma
Read More
Botanical product for hypertriglyceridemia unveiled at recent meeting
Read More
CellGate ciclosporin prodrug shows favorable PK and safety profile following topical administration
Read More
BM-573 prevents coronary artery thrombosis and myocardial infarction
Read More